Therapy of Systemic Rheumatic Disorders Book

Pathogenic Mechanisms as Targets for Therapy in Rheumatoid Arthritis, N. J. Zvaifler Clinical Assessments in Rheumatoid Arthritis, Piet L. C. M. van Riel, Anke M. van Gestel, Maarten Boers, and David L. Scott Prognostic Markers for Rheumatoid Arthritis, Michael J. Green, Charles Richardson, and Paul Emery Clinical Trials Revisited, Harold E. Paulus and Ken J. Bulpitt Second-line Agent Treatment: When and Whom, David L. Scott Aggressive Treatment of Rheumatoid Arthritis: When, Whom, and How, Graciela S. Alarcón Hydroxychloroquine, Howard Bird and Ann W. Morgan D-Penicillamine, Howard Bird and Ann W. Morgan Gold Therapy, Anne McEntegart and Hillary A. Capell Sulfasalazine, Maxime Dougados Methotrexate, Michael Ahern Newer Second-line Agents: Cyclosporin, Theresa Podrebarac and Peter Tugwell Cytotoxics (Azathioprine, Chlorambucil, and Cyclophosphamide), Philip J. Clements Combination Disease-modifying Antirheumatic Drug Therapy, H. James Williams When to Stop Second-line Drugs: Risk/Benefit Ratio of Continuation Versus Cessation in Patients with Rheumatoid Arthritis in Remission, S. ten Wolde and B. A. C. Dijkmans Do Corticosteroids Have a Disease-modifying Role in Rheumatoid Arthritis?, Keith Lim and John R. Kirwan Biological Agents Directed Against Cell Surface Antigens in the Treatment of Rheumatoid Arthritis, Ferdinand C. Breedveld The Clinical Application of Cytokine Blockade in the Therapy of Rheumatoid Arthritis, Diana Davis, Michael J. Elliott, and Ravinder N. Maini Local Therapy for Inflammatory Arthritis, John Edmonds Antibiotic Treatment of Rheumatoid Arthritis, Christopher G. Jackson

Other Polyarthritides

Management of Spondylarthropathy, Maxime Dougados, Michel Revel, and Muhammad Asim Khan Therapy of Systemic Rheumatic Disorders in Children, Anne-Marie Prieur Palindromic Rheumatism and Recurrent Arthritis, Pierre-Andrè Guerne Adult Still's Disease, Pierre-Andrè Guerne

Collagen Vascular Diseases

Systemic Lupus Erythematosus, Naomi F. Rothfield and Ann Parke Therapy of Systemic Sclerosis, Carol Mary Black and Christopher P. Denton Eosinophilic Fasciitis and Eosinophilia-Myalgia Syndrome, Daniel J. Clauw Collagen Vascular Diseases: Polymyositis, Dermatomyositis, and Inclusion Body Myositis, Robert F. Spiera and Lawrence Kagen Taxonomy of the Vasculitis Syndromes, C. G. M. Kallenberg Therapy of Wegener's Granulomatosis, C. G. M. Kallenberg Therapy of Other Vasculitis Syndromes, George D. Kitas, Paul A. Bacon, and Raashid Luqmani Therapy of Sjögren's Syndrome, Panayiotis G. Vlachoyiannopoulos and Haralampos M. Moutsopoulos Management of the Antiphospholipid Syndrome, E. Nigel Harris Second-line Agents in Rheumatic Diseases During Pregnancy, Dafna D. Gladman and Gideon Koren Cytotoxic Drugs and the Risk for Malignancies, Grant W. Cannon